approval
saveTECENTRIQ HYBREZA (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) — FDA approval
community read0 votes
Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 4
- approvalTECENTRIQ HYBREZA (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) — FDA approvalNov 24, 2025 · 311d ago
- approvalTECENTRIQ HYBREZA (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) — FDA approvalNov 17, 2025 · 318d ago
- approvalTECENTRIQ HYBREZA (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) — FDA approvalOct 2, 2025 · 364d ago
- approvalTECENTRIQ HYBREZA (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) — FDA approvalSep 12, 2024 · 749d ago
same company · ±60 days · 6
- approvalatezolizumab: TECENTRIQ (ATEZOLIZUMAB) — FDA approvalAug 18, 2025
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalAug 8, 2025
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalAug 8, 2025
- approvalinavolisib: ITOVEBI (INAVOLISIB) — FDA approvalSep 25, 2025
- approval(atezolizumab + hyaluronidase (human recombinant)): TECENTRIQ HYBREZA (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) — FDA approvalOct 2, 2025
- approvalatezolizumab: TECENTRIQ (ATEZOLIZUMAB) — FDA approvalOct 2, 2025
comments(0)
5-min edit window · permanent after that